Analysis
Moonshot AI, the Beijing-based lab behind Kimi, is preparing to open talks in August for what would be its final pre-IPO funding round, targeting a pre-money valuation of up to $50 billion -- a nearly 60% jump from the $31.5 billion valuation of the round it is currently in the process of closing. The round would be the last outside capital Moonshot takes on before a planned Hong Kong listing that could come before the end of the year.
The timing is directly tied to Kimi K3's momentum: the 2.8-trillion-parameter open-weight model topped a major coding leaderboard shortly after its release and became, by some measures, the largest open-weight model ever published, reigniting investor enthusiasm for Chinese frontier labs just as Moonshot heads into its final pre-listing fundraise.
“Moonshot's trajectory is part of a broader pattern rather than an isolated story.”
Moonshot's trajectory is part of a broader pattern rather than an isolated story. DeepSeek is reportedly targeting a Shanghai STAR Market listing at up to $71 billion as early as the second quarter of 2027, having raised $7.4 billion in June with founder Liang Wenfeng personally committing roughly $3 billion of that round, while MiniMax and Z.ai already completed Hong Kong exchange debuts in January. Collectively, these labs are racing to tap public markets while global attention on Chinese AI capability is at its highest point yet.
For growth investors, a nearly 60% valuation step-up in the final private round before an IPO is a bet that public-market enthusiasm for Chinese AI names will hold through year-end -- a real risk given how quickly sentiment around any single Chinese tech listing can shift on geopolitical or regulatory news.
What to watch: whether Moonshot's August fundraising talks close at or near the $50 billion target, the exact timing of its Hong Kong listing filing, and whether DeepSeek, MiniMax or Z.ai's own public-market performance affects investor appetite for Moonshot's round.
